title: Protein target quantification decision tree.
abstract: The utility of mass spectrometry-(MS-) based proteomic platforms and their clinical applications have become an emerging field in proteomics in recent years. Owing to its selectivity and sensitivity, MS has become a key technological platform in proteomic research. Using this platform, a large number of potential biomarker candidates for specific diseases have been reported. However, due to lack of validation, none has been approved for use in clinical settings by the Food and Drug Administration (FDA). Successful candidate verification and validation will facilitate the development of potential biomarkers, leading to better strategies for disease diagnostics, prognostics, and treatment. With the recent new developments in mass spectrometers, high sensitivity, high resolution, and high mass accuracy can be achieved. This greatly enhances the capabilities of protein biomarker validation. In this paper, we describe and discuss recent developments and applications of targeted proteomics methods for biomarker validation.
authors: Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, 635 Barnhill Drive, MS 4053, Indianapolis, IN 46202, USA.
authors: Jong Won
authors: JW
authors: Kim
authors: Jinsam
authors: J
authors: You
references: J Proteomics. 2011 Nov 18;74(12):2650-9
references: 21540133
references: Clin Chem. 1998 Sep;44(9):2057-60
references: 9733011
references: Sci Rep. 2012;2:220
references: 22355734
references: N Biotechnol. 2009 Dec 31;26(6):269-76
references: 19664732
references: Expert Rev Proteomics. 2012 Apr;9(2):217-30
references: 22462791
references: J Sep Sci. 2005 Sep;28(14):1694-703
references: 16224963
references: Methods. 2006 Apr;38(4):294-303
references: 16481197
references: Anal Chem. 2007 Jun 1;79(11):4199-205
references: 17447729
references: Nat Biotechnol. 2011 Jun 19;29(7):625-34
references: 21685906
references: Proc Natl Acad Sci U S A. 2008 Apr 29;105(17):6320-5
references: 18443287
references: Anal Bioanal Chem. 2004 Feb;378(4):883-97
references: 14647953
references: Circ Heart Fail. 2008 Nov;1(4):258-64
references: 19808300
references: Mol Cell Proteomics. 2002 Nov;1(11):845-67
references: 12488461
references: J Proteome Res. 2010 Sep 3;9(9):4346-55
references: 20684568
references: J Proteomics. 2012 Sep 18;75(17):5507-15
references: 22789673
references: Mol Cell Proteomics. 2011 Feb;10(2):M000062-MCP201
references: 20410378
references: Nat Biotechnol. 2003 Jun;21(6):660-6
references: 12754519
references: Mol Cell Proteomics. 2009 May;8(5):883-6
references: 19131327
references: J Pharm Biomed Anal. 1998 Sep 1;17(6-7):1129-38
references: 9884202
references: Semin Radiat Oncol. 2011 Jan;21(1):10-9
references: 21134649
references: Chem Soc Rev. 2012 May 21;41(10):3912-28
references: 22498958
references: Clin Chem. 2010 Feb;56(2):281-90
references: 20022981
references: Clin Chem. 2005 Dec;51(12):2415-8
references: 16179424
references: Proteomics. 2012 Apr;12(8):1093-110
references: 22577011
references: Mol Cell Proteomics. 2008 Oct;7(10):1824-37
references: 18667414
references: Mol Cell Proteomics. 2009 May;8(5):995-1005
references: 19196707
references: Electrophoresis. 2011 Apr;32(9):967-75
references: 21449066
references: Anal Chem. 2008 Sep 15;80(18):7137-43
references: 18652493
references: Clin Chem. 2010 Feb;56(2):177-85
references: 19884488
references: Expert Rev Proteomics. 2011 Apr;8(2):139-41
references: 21501004
references: Mol Cell Proteomics. 2006 Apr;5(4):573-88
references: 16332733
references: Proc Natl Acad Sci U S A. 2007 Apr 3;104(14):5860-5
references: 17389395
references: Methods Mol Biol. 2010;658:167-85
references: 20839104
references: Mol Cell Proteomics. 2009 Dec;8(12):2687-99
references: 19721077
references: J Proteome Res. 2004 Mar-Apr;3(2):179-96
references: 15113093
references: J Proteome Res. 2007 Nov;6(11):4218-29
references: 17924680
references: Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15395-400
references: 22949669
references: Brief Funct Genomic Proteomic. 2008 Sep;7(5):340-54
references: 18579614
references: Int J Proteomics. 2011;2011:181890
references: 22084682
references: Circulation. 2001 Nov 27;104(22):E125-6
references: 11723038
references: J Proteome Res. 2004 Mar-Apr;3(2):235-44
references: 15113099
references: Drug Metab Lett. 2007 Aug;1(3):226-31
references: 19356047
references: J Proteome Res. 2009 May;8(5):2407-17
references: 19271751
references: Clin Lab Med. 2011 Sep;31(3):371-84
references: 21907103
references: Anal Chem. 2009 May 1;81(9):3462-70
references: 19323455
references: Nat Biotechnol. 2006 Aug;24(8):971-83
references: 16900146
references: Clin Chem. 2010 Feb;56(2):314-8
references: 20022982
references: J Pharm Biomed Anal. 1989;7(2):155-68
references: 2488616
references: Mol Cell Proteomics. 2007 Jan;6(1):141-9
references: 17074749
references: Anal Chem. 2009 Nov 15;81(22):9343-52
references: 19839594
references: Clin Chem. 2008 Nov;54(11):1796-804
references: 18801935
references: J Proteome Res. 2012 Jul 6;11(7):3908-13
references: 22671702
references: Anal Bioanal Chem. 2009 Mar;393(5):1407-16
references: 18807017
references: J Clin Endocrinol Metab. 1998 Apr;83(4):1121-7
references: 9543128
references: Mol Cell Proteomics. 2007 Dec;6(12):2212-29
references: 17939991
references: Methods. 2012 Feb;56(2):246-53
references: 21925605
references: Cardiol Rev. 2001 Nov-Dec;9(6):318-22
references: 11696259